dmd

  1. Presser

    PF-06252616 experimental Myostatin Protein Blocker, to aid in Muscle growth

    <h1>PF-06252616 is an experimental compound designed to block the myostatin protein, a natural limiter of muscle growth. MDA has long supported myostatin inhibition as a potential strategy for the treatment of Duchenne muscular dystrophy and other muscular dystrophies.</h1> BY MARGARET WAHL...
    • Presser
    • Thread
    • boys compound dmd dosage drug dystrophy experimental function group growth inhibition muscle muscular myostatin participants period pf-06252616 pf-0625616 pfizer phase placebo receive sites study trial
    • Replies: 0
    • Forum: Steroids SARMS Peptides Forum
Back
Top